Study S001976

Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart Failure

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06423599
Acronym: FIT-HF
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2; PHASE3
Masking: SINGLE
Status: RECRUITING
Enrollment: 100
Start: 2024-04-30
Primary completion: 2027-12-30
Lead sponsor: Jens D Hove, MD,PHD
Conditions: Heart Failure With Reduced Ejection Fraction; Obesity; Weight Loss; Chronic Heart Failure
Interventions: DRUG:Semaglutide Injectable Product; DIETARY_SUPPLEMENT:Calorie-restricted diet
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: CTIS:2023-503753-35-01; NIH:2023

Registered primary outcomes

Peak oxygen uptake [The patients will be examined after 0, 16 and 52 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.